U.S. Endometriosis Treatment Market (2025 - 2030) Size, Share & Trends Analysis Report By Treatment Type (Pain Medication, Hormone Therapy), By Drug Class (NSAIDs, Oral Contraceptive), By Route Of Administration (Oral), By Distribution Channel, And Segment Forecasts

Table of Contents

Chapter 1 U.S. Endometriosis Treatment Market: Methodology And Scope
                   1.1 Research Methodology
                   1.2 Research Assumptions
                       1.2.1 Estimates And Forecast Timeline
                   1.3 Information Procurement
                       1.3.1 Purchased Database
                       1.3.2 Gvr’s Internal Database
                       1.3.3 Secondary Sources
                       1.3.4 Primary Research
                       1.3.5 Details Of Primary Research
                   1.4 Information Or Data Analysis
                       1.4.1 Data Analysis Models
                   1.5 Market Formulation & Validation
                   1.6 Model Details
                       1.6.1 Commodity Flow Analysis
                           1.6.1.1 Approach 1: Commodity Flow Approach
                       1.6.2 Volume Price Analysis (Model 2)
                           1.6.2.1 Approach 2: Volume Price Analysis
                           1.6.2.2 Revenue Modeling
                   1.7 List Of Secondary Sources
                   1.8 List Of Primary Sources
Chapter 2 U.S. Endometriosis Treatment Market: Executive Summary
                   2.1 U.S. Endometriosis Treatment Market: Market Outlook
                       2.1.1 Market Summary
                   2.2 U.S. Endometriosis Treatment Market: Market Segmentation
                   2.3 U.S. Endometriosis Treatment Market: Competitive Insights
Chapter 3 U.S. Endometriosis Treatment Market: Industry Outlook
                   3.1 U.S. Endometriosis Treatment Market Lineage Outlook
                       3.1.1 Parent Market Outlook
                   3.2 User Perspective Analysis
                   3.3 Penetration & Growth Prospect Mapping
                   3.4 Regulatory And Reimbursement Framework
                   3.5 Market Dynamics
                       3.5.1 Market Driver Analysis
                       3.5.2 Market Restraint Analysis
                   3.6 U.S. Endometriosis Treatment Market Analysis Tools
                       3.6.1 Porter’s Five Forces Analysis
                       3.6.2 Swot Analysis; By Factor (Political & Legal, Economic And Technological)
                       3.6.3 Major Deals & Strategic Alliances Analysis
                           3.6.3.1 New Product Launch
                           3.6.3.2 Mergers And Acquisitions
                           3.6.3.3 Expansion
                           3.6.3.4 Partnerships
                           3.6.3.5 Market Entry Strategies
                   3.7 U.S. Endometriosis Treatment Market Pipeline Analysis
                   3.8 U.S. Endometriosis Treatment Market Unmet Need Analysis
Chapter 4 U.S. Endometriosis Treatment Market: Competitive Landscape
                   4.1 Recent Developments And Impact Analysis, By Key Market Participants
                       4.1.1 Ansoff Matrix
                   4.2 Company Categorization
                       4.2.1 Innovators
                       4.2.2 Market Leaders
                   4.3 Vendor Landscape
                       4.3.1 List Of Key Distributors And Channel Partners
                       4.3.2 Key Customers
                   4.4 Public Companies
                       4.4.1 Company Market Position Analysis
                       4.4.2 Competitive Dashboard Analysis
                           4.4.2.1 Market Differentiators
                   4.5 Private Companies
                       4.5.1 List Of Key Emerging Companies
Chapter 5 U.S. Endometriosis Treatment Market: Treatment Type Business Analysis
                   5.1 U.S. Endometriosis Treatment Market: Treatment Types Movement Analysis
                       5.1.1 Pain Medication
                           5.1.1.1 Pain Medication Market Estimates And Forecast, 2018 - 2030 (USD Million)
                       5.1.2 Hormone Therapy
                           5.1.2.1 Hormone Therapy Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 6 U.S. Endometriosis Treatment Market: Route Of Administration Business Analysis
                   6.1 U.S. Endometriosis Treatment Market: Route Of Administration Movement Analysis
                       6.1.1 Oral
                           6.1.1.1 Oral Market Estimates And Forecast, 2018 - 2030 (USD Million)
                       6.1.2 Injectable
                           6.1.2.1 Injectable Market Estimates And Forecast, 2018 - 2030 (USD Million)
                       6.1.3 Others
                           6.1.3.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 7 U.S. Endometriosis Treatment Market: Drug Class Business Analysis
                   7.1 U.S. Endometriosis Treatment Market: Drug Class Movement Analysis
                       7.1.1 Nsaids
                           7.1.1.1 Nsaids Market Estimates And Forecast, 2018 - 2030 (USD Million)
                       7.1.2 Oral Contraceptive
                           7.1.2.1 Oral Contraceptive Market Estimates And Forecast, 2018 - 2030 (USD Million)
                       7.1.3 Gonadotropin Releasing Hormone
                           7.1.3.1 Gonadotropin Releasing Hormone Market Estimates And Forecast, 2018 - 2030 (USD Million)
                       7.1.4 Others
                           7.1.4.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 8 U.S. Endometriosis Treatment Market: Distribution Channel Business Analysis
                   8.1 U.S. Endometriosis Treatment Market: Distribution Channel Movement Analysis
                       8.1.1 Hospital Pharmacy
                           8.1.1.1 Hospital Pharmacy Market Estimates And Forecast, 2018 - 2030 (USD Million)
                       8.1.2 Retail Pharmacy
                           8.1.2.1 Retail Pharmacy Market Estimates And Forecast, 2018 - 2030 (USD Million)
                       8.1.3 Others
                           8.1.3.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 9 U.S. Endometriosis Treatment Market: Company Profiling
                   9.1 Company Profiles
                       9.6.1 Bayer Ag
                       9.6.2 Pfizer, Inc.
                       9.6.3 Abbvie, Inc.
                       9.6.4 Astrazeneca
                       9.6.5 Obseva Sa
                       9.6.6 Teva Pharmaceutical Industries
                       9.6.7 Zydus Healthcare Limited
                       9.6.8 Eli Lilly And Company
                       9.6.9 Astellas Pharma Inc.

List of Tables

Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. U.S. Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 4. U.S. Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 5. U.S. Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 6. U.S. Endometriosis Treatment Market, Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 U.S. Endometriosis Treatment market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 U.S. Endometriosis Treatment Market Outlook (2021)
Fig. 9 User perspective analysis
Fig. 10 Penetration & growth prospect mapping
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Global population by age group, 2018, 2021, & 2030
Fig. 13 General trend shifts from laboratory to point-of-care
Fig. 14 Market restrain relevance analysis (Current & future impact)
Fig. 15 Porter’s five forces analysis
Fig. 16 SWOT analysis, by factor (Political & legal, economic and technological)
Fig. 17 Strategy mapping
Fig. 18 U.S. Endometriosis Treatment market: Treatment Types outlook and key takeaways
Fig. 19 U.S. Endometriosis Treatment market: Treatment Types movement analysis
Fig. 20 Pain Medication market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Hormone Therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 U.S. Endometriosis Treatment market: Drug Class outlook and key takeaways
Fig. 23 U.S. Endometriosis Treatment market: Drug Class movement analysis
Fig. 24 NSAIDs market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Oral Contraceptivies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Gonadotropin Releasing Hormone market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 U.S. Endometriosis Treatment market: Route of Administration movement analysis
Fig. 29 Oral market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Injectable market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 U.S. Endometriosis Treatment market: Distribution Channel outlook and key takeaways
Fig. 33 U.S. Endometriosis Treatment market: Distribution Channel movement analysis
Fig. 34 Hospital Pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Retail Pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Company market position analysis
Fig. 38 Company market position analysis
Fig. 39 Market differentiators